Last reviewed · How we verify
NCT04091165
Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
trial testing My Plate Calorie Tracker in GI Cancer in 23 participants. Completed in 7 January 2022.
23 July 2020
Quick facts
| Lead sponsor | H. Lee Moffitt Cancer Center and Research Institute |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 23 September 2019 |
| Primary completion | 23 July 2020 |
| Estimated completion | 7 January 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- My Plate Calorie Tracker
Conditions studied
- GI Cancer — all drugs for GI Cancer →
- Nutritional Deficiency — all drugs for Nutritional Deficiency →
Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Who can join
18 and older, any sex, with GI Cancer or Nutritional Deficiency. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is to assess the usability and acceptability of a digital food consumption diary as part of the perioperative management of gastrointestinal oncology patients and to evaluate the impact of a digital food diary on adherence to dietician-recommended plan and on quality recovery, using a commercially available smart phone application.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Pilot trial of remote monitoring to prevent malnutrition after hepatopancreatobiliary surgery.
Allenson K, Turner K, Gonzalez BD, Gurd E, et al · · 2021 · cited 5× · PMID 34886909 · DOI 10.1186/s40795-021-00487-3
Verify or expand the search:
- PubMed search for NCT04091165
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for GI Cancer
Currently open trials in the same condition.
- NCT05804331 — The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study · recruiting
- NCT06040801 — Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Che · NA · recruiting
- NCT05142033 — Avera Cancer Sequencing and Analytics Protocol (ASAP) · recruiting
Other H. Lee Moffitt Cancer Center and Research Institute trials
Trials by the same sponsor.
- NCT05041335 — Wet Heparinized Suction for Abdominal Cancer · NA · not yet recruiting
- NCT07222995 — Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs · NA · recruiting
- NCT06047977 — Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors · Phase 1 · recruiting
- NCT06121180 — Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma · Phase 2 · recruiting
- NCT06193486 — Autologous Gamma Delta T Cells to Target Prostate Stem Cell Antigen in mCRPC · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04091165 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by H. Lee Moffitt Cancer Center and Research Institute
- Last refreshed: 11 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04091165.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing